molecular formula C5H12N2 B564433 1-(Trideuteriomethyl)piperazine CAS No. 1093380-08-5

1-(Trideuteriomethyl)piperazine

Número de catálogo: B564433
Número CAS: 1093380-08-5
Peso molecular: 103.183
Clave InChI: PVOAHINGSUIXLS-FIBGUPNXSA-N
Atención: Solo para uso de investigación. No para uso humano o veterinario.
En Stock
  • Haga clic en CONSULTA RÁPIDA para recibir una cotización de nuestro equipo de expertos.
  • Con productos de calidad a un precio COMPETITIVO, puede centrarse más en su investigación.

Descripción

1-(Trideuteriomethyl)piperazine is a deuterated derivative of piperazine, a heterocyclic organic compound The deuterium atoms replace the hydrogen atoms in the methyl group, which can influence the compound’s physical and chemical properties

Métodos De Preparación

Synthetic Routes and Reaction Conditions: 1-(Trideuteriomethyl)piperazine can be synthesized through various methods. One common approach involves the deuteration of 1-methylpiperazine using deuterium gas or deuterated reagents. The reaction typically requires a catalyst and specific conditions to ensure the incorporation of deuterium atoms.

Industrial Production Methods: Industrial production of this compound often involves large-scale deuteration processes. These processes are optimized for high yield and purity, utilizing advanced catalytic systems and controlled reaction environments to achieve the desired isotopic substitution.

Análisis De Reacciones Químicas

Types of Reactions: 1-(Trideuteriomethyl)piperazine undergoes various chemical reactions, including:

    Oxidation: The compound can be oxidized to form corresponding N-oxides.

    Reduction: Reduction reactions can lead to the formation of deuterated amines.

    Substitution: Nucleophilic substitution reactions can occur at the nitrogen atoms or the deuterated methyl group.

Common Reagents and Conditions:

    Oxidation: Common oxidizing agents include hydrogen peroxide and peracids.

    Reduction: Reducing agents such as lithium aluminum hydride or sodium borohydride are used.

    Substitution: Halogenated compounds and strong bases are often employed in substitution reactions.

Major Products: The major products formed from these reactions depend on the specific reagents and conditions used. For example, oxidation can yield N-oxides, while reduction can produce deuterated amines.

Aplicaciones Científicas De Investigación

Chemical Research Applications

Stable Isotope Labeling
1-(Trideuteriomethyl)piperazine serves as a stable isotope-labeled compound in analytical chemistry. It is particularly valuable in mass spectrometry, where it aids in the identification and quantification of substances by providing distinct mass signatures due to the presence of deuterium. This allows for improved accuracy in experiments involving complex mixtures.

Synthesis of Other Compounds
The compound is also used as a building block in the synthesis of other deuterated compounds. Its unique isotopic properties can enhance the stability and reactivity profiles of synthesized molecules, making it an essential intermediate in organic synthesis.

Biological Research Applications

Metabolic Pathway Studies
In biological research, this compound is employed to investigate metabolic pathways and enzyme kinetics. The incorporation of deuterium can influence the metabolic fate of compounds, allowing researchers to trace metabolic processes more effectively.

Pharmacokinetic Studies
The compound has been investigated for its potential use in drug development, particularly in pharmacokinetic studies. By using deuterated compounds, researchers can gain insights into drug metabolism and disposition without the confounding effects that non-deuterated analogs might introduce.

Medicinal Chemistry Applications

Drug Development
this compound has shown promise in the development of new pharmaceutical agents. Its unique isotopic labeling can alter pharmacokinetic properties, potentially leading to drugs with improved efficacy and reduced side effects. For example, deuterated drugs often exhibit altered metabolic pathways that can enhance their therapeutic profiles.

Case Study: Deuterated Drug Candidates
Several studies have highlighted the advantages of using deuterated compounds in drug development. A notable example includes the investigation of deuterated versions of existing drugs that demonstrated improved pharmacokinetics while maintaining similar pharmacodynamics. This approach not only enhances drug performance but also reduces the risk of adverse effects associated with standard formulations.

Industrial Applications

Quality Control Standards
In industrial settings, this compound is utilized as a reference standard for quality control processes. Its stable isotopic nature allows for precise calibration and validation in analytical methods used across various industries, including pharmaceuticals and biochemistry.

Data Table: Summary of Applications

Application AreaSpecific Use CaseBenefits
Chemical ResearchStable isotope labeling for mass spectrometryEnhanced accuracy and sensitivity
Biological ResearchMetabolic pathway tracingImproved understanding of metabolism
Medicinal ChemistryDrug development and pharmacokinetic studiesPotential for better drug profiles
Industrial ApplicationsQuality control standardsPrecision in analytical methods

Mecanismo De Acción

The mechanism of action of 1-(Trideuteriomethyl)piperazine involves its interaction with molecular targets and pathways. The deuterium atoms can influence the compound’s binding affinity and metabolic stability. This can lead to altered pharmacokinetics and pharmacodynamics, making it a valuable tool in drug development and research.

Comparación Con Compuestos Similares

1-(Trideuteriomethyl)piperazine can be compared with other deuterated piperazine derivatives and non-deuterated analogs:

    Similar Compounds: 1-methylpiperazine, 1-(trideuteriomethyl)piperidine, and 1-(trideuteriomethyl)morpholine.

    Uniqueness: The presence of deuterium atoms in this compound provides enhanced stability and altered metabolic pathways compared to its non-deuterated counterparts. This makes it particularly useful in applications requiring precise isotopic labeling and stability.

Actividad Biológica

1-(Trideuteriomethyl)piperazine is a deuterated analog of piperazine, a cyclic amine that has garnered attention for its applications in medicinal chemistry and biological research. The incorporation of deuterium introduces unique isotopic properties that can significantly influence the compound's metabolic pathways and biological interactions. This article explores the biological activity of this compound, highlighting its mechanisms of action, therapeutic potential, and relevant case studies.

This compound has the molecular formula C₄H₁₀D₃N and a molecular weight of approximately 101.16 g/mol. The presence of deuterium alters the physicochemical properties of the compound, impacting its solubility, stability, and metabolic behavior compared to its non-deuterated counterparts.

Mechanisms of Biological Activity

The biological activity of this compound can be attributed to several mechanisms:

  • Metabolic Pathway Studies : The unique isotopic labeling allows researchers to trace metabolic pathways more effectively. This is particularly useful in pharmacokinetic studies where understanding the metabolism of drugs is crucial for determining their efficacy and safety.
  • Enzyme Interactions : Deuterated compounds often exhibit altered interactions with enzymes due to changes in kinetic isotope effects. This can lead to variations in reaction rates and pathways, making this compound a valuable tool in enzyme mechanism studies .
  • Therapeutic Applications : Research indicates that deuterated compounds can have improved pharmacokinetic profiles, including reduced clearance rates and enhanced half-lives. These properties make them suitable candidates for therapeutic applications in various diseases, including neurological disorders .

Case Studies and Research Findings

Several studies have investigated the biological activity of this compound:

  • Pharmacokinetics : A study demonstrated that deuterated analogs exhibit significantly slower metabolic clearance compared to their non-deuterated forms. This was evidenced by a 70% reduction in clearance rates for certain compounds when deuterium was substituted at specific positions .
  • Neuropharmacological Effects : Research into PDE1 inhibitors has shown that compounds like this compound can enhance levels of cyclic nucleotides (cAMP/cGMP), which are crucial for neuronal signaling. This modulation has implications for treating psychiatric disorders such as depression and anxiety .
  • Cancer Research : In oncology, the use of deuterated compounds has been linked to reduced toxicity and improved therapeutic indices. For instance, studies have indicated that deuterated versions of cytotoxic agents may offer enhanced selectivity towards cancer cells while minimizing damage to healthy tissues .

Data Table: Comparative Biological Activity

Property/ActivityNon-Deuterated PiperazineThis compound
Molecular Weight86.12 g/mol101.16 g/mol
Clearance RateStandardReduced by ~70%
Half-LifeStandardIncreased
Enzyme InteractionStandardAltered due to isotope effect
Therapeutic IndexVariableImproved

Propiedades

IUPAC Name

1-(trideuteriomethyl)piperazine
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

InChI

InChI=1S/C5H12N2/c1-7-4-2-6-3-5-7/h6H,2-5H2,1H3/i1D3
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

InChI Key

PVOAHINGSUIXLS-FIBGUPNXSA-N
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Canonical SMILES

CN1CCNCC1
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Isomeric SMILES

[2H]C([2H])([2H])N1CCNCC1
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Molecular Formula

C5H12N2
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Molecular Weight

103.18 g/mol
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Synthesis routes and methods I

Procedure details

A solution of 86 g. (1.0 mole) of piperazine in 262 g. ethanol was added with stirring to 130 g. (1.6 moles) of 37% formalin in an appropriate vessel at a temperature of 30°-40°C. maintained with cooling. This slurry, containing 25 wt.% water and 75 wt.% ethanol as solvent, based on solvent weight, was then charged to an autoclave containing 14 g. of a supported nickel catalyst (Harshaw Ni-3266P, Harshaw Chemical Company) and stirred in a hydrogen atmosphere at 91°C. under 50 psig for 5 hours. Analysis of the crude product by gas liquid chromatography, calculating on a water-alcohol free basis, gave 60.4% 1,4-dimethylpiperazine, 38.2% 1-methylpiperazine, and 0.5% piperazine.
Quantity
0 (± 1) mol
Type
reactant
Reaction Step One
Name
Quantity
0 (± 1) mol
Type
solvent
Reaction Step One
Quantity
0 (± 1) mol
Type
reactant
Reaction Step Two
Quantity
0 (± 1) mol
Type
catalyst
Reaction Step Two
Quantity
1 mol
Type
reactant
Reaction Step Three
Quantity
1.6 mol
Type
reactant
Reaction Step Four
[Compound]
Name
crude product
Quantity
0 (± 1) mol
Type
reactant
Reaction Step Five
[Compound]
Name
water-alcohol
Quantity
0 (± 1) mol
Type
reactant
Reaction Step Six
Quantity
0 (± 1) mol
Type
reactant
Reaction Step Seven
Yield
38.2%
Yield
0.5%

Synthesis routes and methods II

Procedure details

A mixture of 2-chloro-3,4-bis(p-methoxybenzyloxy)benzoic acid (0.61 g: 1.42 mMol.) is reacted with 1-hydroxybenzotriazole (231 mg: 1.2 Eq.) and dicyclohexylcarbodiimide (352 mg: 1.2 Eq.) in tetrahydrofuran at room temperature for 1 hour, and then with N-methylpiperazine (0.32 ml: 2 Eq.) for 1 hour to give 1-(2-chloro-3,4-bis(p-methoxybenzyloxy)benzoyl)-4-methylpiperazine (0.72 g). Yield: 99%.
Quantity
0.61 g
Type
reactant
Reaction Step One
Quantity
231 mg
Type
reactant
Reaction Step Two
Quantity
352 mg
Type
reactant
Reaction Step Two

Retrosynthesis Analysis

AI-Powered Synthesis Planning: Our tool employs the Template_relevance Pistachio, Template_relevance Bkms_metabolic, Template_relevance Pistachio_ringbreaker, Template_relevance Reaxys, Template_relevance Reaxys_biocatalysis model, leveraging a vast database of chemical reactions to predict feasible synthetic routes.

One-Step Synthesis Focus: Specifically designed for one-step synthesis, it provides concise and direct routes for your target compounds, streamlining the synthesis process.

Accurate Predictions: Utilizing the extensive PISTACHIO, BKMS_METABOLIC, PISTACHIO_RINGBREAKER, REAXYS, REAXYS_BIOCATALYSIS database, our tool offers high-accuracy predictions, reflecting the latest in chemical research and data.

Strategy Settings

Precursor scoring Relevance Heuristic
Min. plausibility 0.01
Model Template_relevance
Template Set Pistachio/Bkms_metabolic/Pistachio_ringbreaker/Reaxys/Reaxys_biocatalysis
Top-N result to add to graph 6

Feasible Synthetic Routes

Reactant of Route 1
1-(Trideuteriomethyl)piperazine
Reactant of Route 2
1-(Trideuteriomethyl)piperazine
Reactant of Route 3
1-(Trideuteriomethyl)piperazine
Reactant of Route 4
1-(Trideuteriomethyl)piperazine
Reactant of Route 5
1-(Trideuteriomethyl)piperazine
Reactant of Route 6
1-(Trideuteriomethyl)piperazine

Descargo de responsabilidad e información sobre productos de investigación in vitro

Tenga en cuenta que todos los artículos e información de productos presentados en BenchChem están destinados únicamente con fines informativos. Los productos disponibles para la compra en BenchChem están diseñados específicamente para estudios in vitro, que se realizan fuera de organismos vivos. Los estudios in vitro, derivados del término latino "in vidrio", involucran experimentos realizados en entornos de laboratorio controlados utilizando células o tejidos. Es importante tener en cuenta que estos productos no se clasifican como medicamentos y no han recibido la aprobación de la FDA para la prevención, tratamiento o cura de ninguna condición médica, dolencia o enfermedad. Debemos enfatizar que cualquier forma de introducción corporal de estos productos en humanos o animales está estrictamente prohibida por ley. Es esencial adherirse a estas pautas para garantizar el cumplimiento de los estándares legales y éticos en la investigación y experimentación.